SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Jun 11, 2019
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: June 11, 2019 · CIK: 0001279704 · Accession: 0001144204-19-030501
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231888
Letter
CELLECTAR BIOSCIENCES, INC.
100 Campus Drive
Florham Park, New Jersey 07932
June 11, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joseph McCann
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed May 31, 2019
File No. 333-231888
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-231888), as amended, be accelerated so that the Registration Statement will become effective at 5:00 p.m. on June 11, 2019, or as soon as practicable thereafter.
The cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Gregory J. Lynch (608-283-2240 or gjlynch@michaelbest.com) or Joshua B. Erekson (801-833-0505 or jberekson@michaelbest.com). Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CELLECTAR BIOSCIENCES, INC.
100 Campus Drive
Florham Park, New Jersey 07932
June 11, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joseph McCann
Re:
Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed May 31, 2019
File No. 333-231888
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities
Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that
the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-231888), as amended, be accelerated
so that the Registration Statement will become effective at 5:00 p.m. on June 11, 2019, or as soon as practicable thereafter.
The
cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact
Gregory J. Lynch (608-283-2240 or gjlynch@michaelbest.com) or Joshua B. Erekson (801-833-0505 or jberekson@michaelbest.com).
Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
By:
/s/ James V. Caruso
James V. Caruso, President and Chief Executive Officer
cc:
Charles T. Bernhardt
Gregory J. Lynch
Joshua B. Erekson